317 related articles for article (PubMed ID: 8361131)
21. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
22. Role of the renal nerves and angiotensin II in the renal function curve.
Golin R; Genovesi S; Castoldi G; Wijnmaalen P; Protasoni G; Zanchetti A; Stella A
Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.
Wapstra FH; Navis G; de Jong PE; de Zeeuw D
Exp Nephrol; 1996; 4 Suppl 1():47-52. PubMed ID: 9001897
[TBL] [Abstract][Full Text] [Related]
25. Intrarenal production of angiotensin II.
Navar LG; Imig JD; Zou L; Wang CT
Semin Nephrol; 1997 Sep; 17(5):412-22. PubMed ID: 9316209
[TBL] [Abstract][Full Text] [Related]
26. Requirement of drug development for chronic renal disease: Other strategies than blockade of the renin-angiotensin system.
Okamoto T
Int J Mol Med; 2003 May; 11(5):651-4. PubMed ID: 12684706
[TBL] [Abstract][Full Text] [Related]
27. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
28. Localization of components of the renin-angiotensin system within the kidney.
Inagami T; Kawamura M; Naruse K; Okamura T
Fed Proc; 1986 Apr; 45(5):1414-9. PubMed ID: 3514278
[TBL] [Abstract][Full Text] [Related]
29. Influence of dietary factors on the renal renin-angiotensin system.
Wagner J; Stein G; Mann J; Ritz E
Klin Wochenschr; 1992; 69 Suppl 29():35-8. PubMed ID: 1614190
[TBL] [Abstract][Full Text] [Related]
30. Role of the renin-angiotensin system in the regulation of glomerular filtration.
Sraer JD; Kanfer A; Rondeau E; Lacave R
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S21-5. PubMed ID: 2483424
[TBL] [Abstract][Full Text] [Related]
31. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
[TBL] [Abstract][Full Text] [Related]
32. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
Sandmann S; Unger T
Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
[TBL] [Abstract][Full Text] [Related]
33. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
34. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
35. Long-term renoprotective effect of combination therapy with prostaglandin E1 and angiotensin-converting enzyme inhibitor in patients with chronic renal failure.
Nakayama Y; Nonoguchi H; Kiyama S; Kohda Y; Inoue T; Tomita K
Hypertens Res; 2005 Sep; 28(9):733-9. PubMed ID: 16419646
[TBL] [Abstract][Full Text] [Related]
36. The renin-angiotensin system. New concepts in regulation of blood pressure and renal function.
Goldfarb DA
Urol Clin North Am; 1994 May; 21(2):187-94. PubMed ID: 8178386
[TBL] [Abstract][Full Text] [Related]
37. Influences of angiotensin on renal function in renal vascular hypertension.
Ploth DW
Kidney Int Suppl; 1990 Nov; 30():S97-101. PubMed ID: 2259086
[TBL] [Abstract][Full Text] [Related]
38. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
Dzau VJ
Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
[TBL] [Abstract][Full Text] [Related]
39. Converting enzyme inhibition: implications for renal perfusion and function.
Hollenberg NK
Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
[TBL] [Abstract][Full Text] [Related]
40. Renal protective effects of blocking the intrarenal renin-angiotensin system: angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor.
Zhou A; Yu L; Li J; Zhang J; Wang H
Hypertens Res; 2000 Jul; 23(4):391-7. PubMed ID: 10912779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
